Home
Charles McWherter, President of R&D: CymaBay Therapeutics CBAY Sell · Filed 23/10/18
Trade details
- Type
- Insider sale
- Amount
- $305,924.01
- Shares · price
- 21,743 sh · $14.07 a share
- Held after
- 15,000 sh
- Trade date
- 23/10/18
- Filed
- 23/10/18
- Days to filing
- 0 days
Sold 59.2% of holdings
- Share of holding sold
- 59.2%
CymaBay Therapeutics trades, last 26 weeks
What else happened in CymaBay Therapeutics around then
Filed or reported within 30 days of the trade day · 23/09/18~23/11/17Charles McWherter's recent trades
- Charles McWherter
Buy89bio
Buy89bio
ETNB
$67.1K
10,000 sh
$67.1K
Filed 25/01/23
Traded 25/01/22
- Charles McWherter
Buy89bio
Buy89bio
ETNB
$32.8K
5,000 sh
$32.8K
Filed 25/01/23
Traded 25/01/21
- Charles McWherter
Buy89bio
Buy89bio
ETNB
$80K
10,000 sh
$80K
Filed 24/12/09
Traded 24/12/05
- Charles McWherter
Sell10b5-1 planCymaBay Therapeutics
Sell10b5-1 planCymaBay Therapeutics
CBAY
$197.3K
8,334 sh
$197.3K
Filed 24/01/22
Traded 24/01/19
- Charles McWherter
Sell10b5-1 planCymaBay Therapeutics
Sell10b5-1 planCymaBay Therapeutics
CBAY
$74K
3,125 sh
$74K
Filed 24/01/22
Traded 24/01/19